Showing results (61-70 of 444) with videos related to
Sort By:
Pageof 45
Clinical Genitourinary Cancer|December 5, 2025
Ipilimumab and Nivolumab in Renal Cell Carcinoma: Real-World Experience in Rare Variant Renal Cell Carcinoma, Brain Metastases and Impact of Immune-Related Adverse Events and Steroid UseTobias Peres, James LarkinExpert Review of Anticancer Therapy|June 13, 2017
Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapyAine O'reilly, James LarkinExpert Review of Clinical Pharmacology|February 23, 2017
Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapyAine O'Reilly, James LarkinHuman Molecular Genetics|April 20, 2022
Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma casesBryndis Yngvadottir, Avgi Andreou, Laia Bassaganyas, et al.Nature Communications|July 15, 2024
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Culliford, Samuel E D Lawrence, Charlie Mills, et al.Cell Reports|May 7, 2020
Representative Sequencing: Unbiased Sampling of Solid Tumor TissueKevin Litchfield, Stacey Stanislaw, Lavinia Spain, et al.Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.Expert Opinion on Pharmacotherapy|April 29, 2014
New RAF kinase inhibitors in cancer therapyJuan Martin-Liberal, James LarkinFuture Oncology (London, England)|February 17, 2015
Vemurafenib for the treatment of BRAF mutant metastatic melanomaJuan Martin-Liberal, James LarkinPageof 45